We provide integrated services across:
Apr 11, 2025
What technology areas can we support?
We provide integrated services across:
- Autologous and allogeneic cell therapies (e.g. T cells, iPSCs, MSCs)
- Viral vectors (e.g. AAV, lentivirus, including scalable suspension processes)
- RNA technologies (e.g. mRNA, saRNA, cRNA with LNP encapsulation) We support process development, tech transfer, GMP manufacturing, and fill finish for these modalities within a single site.
Latest News
eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies
Dec 2, 2025
Industry News
eXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway
Nov 26, 2025
Industry News
eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading CGT services in Southeast Asia
Sep 23, 2025
Industry News
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.